Glaukos Corp. today announced it received FDA approval for Epioxa, an eye therapy made to stop the progression of keratoconus.

SATURDAY’S 2-1 win at Loftus Road was not the easiest on the eyes. It was a physical, nasty, combative affair that Millwall ...

Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to corneal cross-linking ...

The 367-page-long book contains detailed accounts of Giuffre's encounters with Jeffrey Epstein, Ghislaine Maxwell and Prince ...

Minimally invasive endoscopic surgery may be an effective and safe treatment for patients with intracerebral hemorrhage, the ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...

The advancements of minimally invasive cardiac surgery for seniors often give them a better chance for a speedy recovery, as ...

Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the ...

Should I have my cat neutered? But what exactly happens during the procedure, when is the right time, and what persistent ...